From: A mixed methods approach to understand variation in lung cancer practice and the role of guidelines
LHIN | Guideline treatment (RCC) | Treated non-RCC | Alternate treatment | No treatment <120 days of Surgery | Total resected II&IIIA cases |
---|---|---|---|---|---|
1 | 32% | 6% | 3% | 59% | 34 |
2 | 38% | 4% | 4% | 53% | 68 |
3 | 16% | 19% | 19% | 47% | 43 |
4 | 46% | 2% | 7% | 46% | 61 |
5 | 10% | 41% | 10% | 38% | 29 |
6 | 32% | 27% | 5% | 35% | 37 |
7 | 29% | 32% | 5% | 34% | 65 |
8 | 40% | 25% | 3% | 32% | 68 |
9 | 49% | 11% | 6% | 34% | 83 |
10 | 52% | 4% | 11% | 33% | 27 |
11 | 61% | 1% | 7% | 31% | 72 |
12 | 37% | 24% | 11% | 28% | 46 |
13 | 50% | 4% | 4% | 42% | 50 |
14 | 65% | 0% | 10% | 25% | 20 |
Ontario | 41% | 14% | 7% | 38% | 703 |